đ
The FDA has approved the drug Relyvrio, which was shown in studies to extend the lives of people with ALS by about 6 months.
đ
The FDA has approved the drug Relyvrio, which was shown in studies to extend the lives of people with ALS by about 6 months.
Comments are closed.